[Fluorometholon/tetryzoline in the treatment of conjunctival irritation].
The clinical efficacy of Efemoline eyedrops [fluourometholone (0.1%) + tetryzoline (0.25%)] and of fluorometholone 0.1% was investigated in a double-blind controlled clinical trial in 35 patients (63 eyes) in treatment of the upper bulbus area and postoperatively after surgery for cataract, glaucoma and strabismus. Both drugs were effective inflammation inhibitors. The superiority of fluorometholone + tetryzoline over fluorometholone was evident: subjective symptoms improved much more quickly. No tendency toward elevation of intraocular pressure was found. The combined preparation was compatible and produced no side-effects.
D000328:Adult; D002986:Clinical Trials as Topic; D003231:Conjunctivitis / Q000188:drug therapy*; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D005469:Fluorometholone / Q000008:administration & dosage*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D008297:Male; D009883:Ophthalmic Solutions
D004338:Drug Combinations; D007093:Imidazoles; D009883:Ophthalmic Solutions; C005810:tetrahydrozoline; D005469:Fluorometholone
Fluorometholon/Tetryzolin zur Behandlung konjunktivaler Reizzustände.